Browsing: Homepage Slider
0 COVID-19: Updates on vaccines and therapeutics
Take a look at our day-by-day updates covering the latest on therapeutics and vaccines for COVID-19, from new partnerships to clinical trials..
0 Vaccination and the immunocompromised population – an interview with Deepali Kumar
In this interview we speak to Deepali Kumar about vaccination in the immunocompromised population, including guideline updates, understanding immunology and the future of this field.
0 In focus: Coronavirus
Discover the latest updates on the ongoing novel coronavirus outbreak in the ‘COVID-19 Hub’, powered by Infectious Diseases Hub and…
0 COVID-19: First patients dosed in Phase I vaccine trial
Moderna has announced that the first participants have been dosed in a Phase I study of their mRNA candidate vaccine against SARS-CoV-2, the virus that causes COVID-19.
1 Coronavirus: facts versus fiction
There has been a lot of media attention on COVID-19, and alongside valuable reporting there have also been myths and false facts spread through social media and other channels, so what are the key facts about this coronavirus?
0 Malaria: triple artemisinin-based combination therapies safe and effective
The first clinical trial assessing two triple artemisinin-based combination therapies (TACTs) for treating malaria has suggested these are effective and present no safety concerns.
1 What role can the media play in managing the COVID-19 outbreak?
The media are uniquely placed to impact what the public think and feel. During outbreaks what challenges are facing journalists? Editor, Martha Powell, asks how we can ensure we’re undertaking reporting responsibly?
0 Universal vaccines: A holy grail for the flu?
In this blog, we review some of the main targets of universal vaccines and the key challenges to their successful implementation.
0 Could obesity promote virulence in influenza?
A mouse study has revealed that obesity may be one factor explaining the significant amount of variation in the influenza virus each year, likely due to an impaired interferon defense response.
0 The race for COVID-19 treatments and vaccines: February’s industry headlines
Catch up on February’s industry headlines, including an MRSA breakthrough, a patent lawsuit, and the latest updates on the coronavirus outbreak and its impact on the biotechnology industry worldwide.
